Company Search:
Advanced Search
Sponsored Links
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in AUSTRALIA : Immutep Ltd (2020 sales of 13.94 million Australian Dollars [US$10.76 million] of which 99% was Cancer Immunotherapy), Idt Australia Limited. (14.17 million Australian Dollars [US$10.94 million] ), and Cellmid Limited (7.48 million Australian Dollars [US$5.78 million] of which 79% was Advangen Japan).

Sales Analysis. During the year ended June of 2020, sales at Pharmaxis Ltd were A$12.55 million (US$9.69 million). This is a very small increase of 0.0% versus 2019, when the company's sales were A$12.55 million. Despite this increase, sales are still well below the level achieved in 2018, when Pharmaxis Ltd reported sales of A$50.33 million. Sales of Mannitol saw an increase that was more than double the company's growth rate: sales were up 23.6% in 2020, from A$5.70 million to A$7.05 million. Not all segments of Pharmaxis Ltd experienced an increase in sales in 2020: sales of New Drug Development fell 13.5% to A$5.16 million. Pharmaxis Ltd also experienced decreases in sales in Corporate (down 9.3% to A$459,000.00 ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): .08
(Figures in Australian Dollars)
1 Week -2.4%   13 Weeks 1.3%  
4 Weeks -12.0%   52 Weeks -19.0%  
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 12,550,000
(Year Ending Jan 2021).
Employees: 107
  Currency: Australian Dollars Market Cap: 32,171,564
  Fiscal Yr Ends: June Shares Outstanding: 397,179,798
  Share Type: Ordinary Closely Held Shares: 36,456,738
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.